Back to Search
JOHN P FRUEHAUF, MD
MD
Hematology & Oncology Physician
NPI: 1588744635IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
000000G58826(CA)
Education
RUSH MEDICAL COLLEGE OF RUSH UNIVERSITY
Class of 1985
Research & Publications (20)
In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.
PMID 16899598·Clin Cancer Res·2006
8-other
Docetaxel and vinorelbine plus GM-CSF in malignant melanoma.
PMID 15934496·Oncology (Williston Park)·2005
3-trial
In vitro assay-assisted treatment selection for women with breast or ovarian cancer.
PMID 12237245·Endocr Relat Cancer·2002
6-review
Reactive oxygen species: an Achilles' heel of melanoma?
PMID 18983235·Expert Rev Anticancer Ther·2008
6-review
Assay-assisted treatment selection for women with breast or ovarian cancer.
PMID 12528805·Recent Results Cancer Res·2003
6-review
Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
PMID 19110305·Gynecol Oncol·2009
3-trial
Transkingdom RNA interference (tkRNAi): a novel method to induce therapeutic gene silencing.
PMID 19048211·Methods Mol Biol·2009
7-preclinical
Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.
PMID 19482027·Gastroenterology·2009
7-preclinical
In vitro and in vivo gene silencing by TransKingdom RNAi (tkRNAi).
PMID 19301646·Methods Mol Biol·2009
7-preclinical
Prediction of drug response in breast cancer using integrative experimental/computational modeling.
PMID 19366802·Cancer Res·2009
8-other
Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signaling.
PMID 19018094·Blood·2009
8-other
High-intensity focused ultrasound for the targeted destruction of uterine tissues: experiences from a pilot study using a mobile HIFU unit.
PMID 17823809·Arch Gynecol Obstet·2008
8-other
The effect of bevacizumab (Avastin) on neuroimaging of brain metastases.
PMID 18261776·Surg Neurol·2008
5-case
Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance.
PMID 18694961·Mol Cell Biol·2008
8-other
Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
PMID 17932890·Cancer·2007
4-observational
Cequent Pharmaceuticals, Inc.: the biological pitcher for RNAi therapeutics.
PMID 18240911·Pharmacogenomics·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UCI MEDICAL CENTER, 101 THE CITY DRIVE SOUTH
ORANGE, CA 92868 - Phone
- (714) 456-8978
Quick Facts
- NPI
- 1588744635
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile